Embolization of porto-systemic shunt as treatment for recurrent hepatic encephalopathy
Journal Title: Annals of Hepatology - Year 2014, Vol 13, Issue 5
Abstract
Authors and Affiliations
Hugh Leonard, James O’Beirne, Dominic Yu, Emmanuel Tsochatzis
Keywords
Related Articles
- EP ID EP78440
- DOI -
- Views 97
- Downloads 0
Early initiation of MARS® dialysis in Amanita phalloides-induced acute liver injury prevents liver transplantation
Amanita phalloides is the most relevant mushroom intoxication leading to acute liver failure. The two principal groups of toxins, the amatoxins and the phallotoxins, are small oligopeptides highly resistant to chemical...
Polycystic liver disease: a clinical review
Polycystic liver disease rarely occurs in isolation as part of autosomal dominant polycystic liver disease, but more commonly, it exists as an extra-renal manifestation of autosomal dominant polycystic kidney disease. T...
Cholestasis as the initial presentation of relapsing polychondritis
Relapsing polychondritis is an immune-mediated disease associated with inflammation in cartilaginous structures and other tissues throughout the body, particularly the ears, nose, eyes, joints, and respiratory tract. Alt...
Dress syndrome and fulminant hepatic failure induced by lamotrigine
Lamotrigine is a non-aromatic antiepileptic drug. Drug rash with eosinophilia and systemic symptoms (DRESS) syndrome is a severe idiosyncratic reaction to drugs, especially anti-epileptic drugs. Associated clinical featu...
Is pre-treatment liver biopsy necessary for all hepatitis C genotypes?
Background. Current practice guidelines recommend liver biopsy prior to treatment of hepatitis C genotype-1 but not for genotype-2/3; this is based on expert opinion, not on published evidence. Methods. In retrospective...